IN HER SHOES. BUT SHE’S TAKEN A HORRIBLE SITUATION AND SHE’S SOMEHOW MANAGING TO FIND A WAY TO LIVE THROUGH IT AND DO IT WITH GRACE AND INSPIRING SO MANY PEOPLE. AND WE’RE FOLLOWING THE JOURNEY OF ...

HealthDay News — Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better ...

ROANOKE, Va. – It’s estimated that more than 42,000 people will die from breast cancer this year, according to the American Cancer Society. To help you understand if you’re at a greater risk of ...

Devin Sidell wanted to make a movie about her experience having a preventative double mastectomy after her mother was ...

Genetic testing, including germline and somatic, is vital for prostate cancer prognosis and personalized treatment strategies. PARP inhibitors, targeting BRCA mutations, are a promising therapy for ...

BRCA genetic mutations, which are 10 times more common among Ashkenazi Jews than among the general U.S. population, significantly increase the risks of developing breast cancer and ovarian cancer. In ...

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host and producer of TED Health, and founder of End Well, a nonprofit ...

Rubby X-ray inspection Breast cancer is one of the most common cancers in women, and the incidence rate is steadily increasing at home and abroad. Although the causes of the outbreak vary, genetic ...

Please provide your email address to receive an email when new articles are posted on . Only in her mid-20s at the time, Olumba wasn’t ready to undergo a prophylactic mastectomy. “I was young and, ...

Pathway Genomics said that it has launched BRCATrue, a next- generation sequencing and deletion/duplication analysis that can detect mutations in BRCA1 and BRCA2, the genes linked to breast, ovarian ...

As part of the ACLU's Taking Back Our Genes campaign , guest blogger Sue Friedman, the Executive Director of FORCE, describes the adverse impact the exclusive patents on BRCA1 and BRCA2 have on the ...

Credit: Getty Images Determining the presence or absence of gene mutations associated with aggressive prostate cancer can have implications for risk stratification, monitoring, and therapy. Genetic ...